Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: Report of a case

Diseases of the Colon and Rectum

Volumn 51, Issue 9, 2008, Pages 1425-1426

  Koopman, Miriam ^a   Muller, Erik W ^b   Punt, Cornelis J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLINGELAND HOSPITAL   (Netherlands)

Author keywords

Bevacizumab; Colorectal cancer; Hypertension; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; COLORECTAL CANCER; COMA; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; LEUKOENCEPHALOPATHY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PRACTICE GUIDELINE; SYMPTOMATOLOGY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIHYPERTENSIVE AGENTS; COLORECTAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 49749145903     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9282-8     Document Type: Article

References (3)

1. J Hinchey C Chaves B Appignani 1996 A reversible posterior leukoencephalopathy syndrome N Engl J Med 334 494 500
2. C Ozcan SJ Wong P Hari 2006 Reversible posterior leukoencephalopathy syndrome and bevacizumab N Engl J Med 354 980 982
3. P Glusker L Recht B Lane 2006 Reversible posterior leukoencephalopathy syndrome and bevacizumab N Engl J Med 354 980 982